Bristol-Myers Squibb Co. has reached an agreement to sell its OTC assets in Asia-Pacific,
excluding China and Japan, to Taisho Pharmaceutical Co. for $310 million.
With the asumption, value of transaction in Indonesia US$150 million Taisho must tender offer shares of Bristol Myers at price IDR149.517.
Wednesday, September 16, 2009
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment